These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum. Cotman SL; Karaa A; Staropoli JF; Sims KB Curr Neurol Neurosci Rep; 2013 Aug; 13(8):366. PubMed ID: 23775425 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and treatment of neuronal ceroid lipofuscinoses from the viewpoint of neuropediatricians]. Steinfeld R Ophthalmologe; 2010 Jul; 107(7):616-20. PubMed ID: 20454899 [TBL] [Abstract][Full Text] [Related]
11. Cell biology of the NCL proteins: What they do and don't do. Cárcel-Trullols J; Kovács AD; Pearce DA Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2242-55. PubMed ID: 25962910 [TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis]. Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038 [TBL] [Abstract][Full Text] [Related]
13. The neuronal ceroid-lipofuscinoses. Bennett MJ; Rakheja D Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013 [TBL] [Abstract][Full Text] [Related]
14. Neuronal ceroid-lipofuscinoses: the current status. Goebel HH Brain Dev; 1992 Jul; 14(4):203-11. PubMed ID: 1443397 [TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of the neuronal ceroid lipofuscinoses. Mole S; Gardiner M Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748 [TBL] [Abstract][Full Text] [Related]
16. Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases. von Schantz C; Saharinen J; Kopra O; Cooper JD; Gentile M; Hovatta I; Peltonen L; Jalanko A BMC Genomics; 2008 Mar; 9():146. PubMed ID: 18371231 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063 [TBL] [Abstract][Full Text] [Related]
18. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry. Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and genetic description of neuronal ceroid lipofuscinosis 6 type in the yakut family]. Golikova PI; Petukhova DA; Sukhomyasova AL; Nikolaeva TY; Gurinova EE; Ivanova RN; Maksimova NR Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):71-76. PubMed ID: 34481439 [TBL] [Abstract][Full Text] [Related]